Document:

AGREEMENT FOR THE PAYMENT OF BENEFITS FOLLOWING TERMINATION OF EMPLOYMENT

 Exhibit 10.23 
 FORM OF 
 AGREEMENT FOR THE PAYMENT OF BENEFITS 

FOLLOWING TERMINATION OF EMPLOYMENT 
 AGREEMENT dated as of October 4, 2011 (the “Effective Date”) between Beam Inc., a Delaware corporation (the “Company”), and
                             (the “Executive”), 

W I T N E S S E T H: 

WHEREAS, the Executive is employed by the Company; and 
 WHEREAS, the Company and the Executive desire to enter into this Agreement to set forth the benefits to be provided to the Executive in the event that his or her employment terminates under the
circumstances described herein. 
 NOW, THEREFORE, in consideration of the foregoing, the parties agree as follows: 

 

	 	1.	Definitions. For purposes of this Agreement, the following terms shall have the meanings set forth below: 

 

	 	(a)	Cause. “Cause” shall mean: 

 (i) the Executive’s willful and continuous failure to substantially perform his or her material duties (other than a failure due to a Disability); 

(ii) the commission of any activities constituting a violation or breach under any federal, state or local law or
regulation applicable to the activities of the Company, as determined in the reasonable judgment of the Company; 

(iii) fraud, breach of fiduciary duty, dishonesty, misappropriation or other actions that cause significant damage to the
property or business of the Company; 
 (iv) repeated absences from work such that the Executive is unable to
perform his or her employment or other duties in all material respects, other than due to Disability; 
 (v)
admission or conviction of, or plea of nolo contendere, to any felony that, in the reasonable judgment of the Company, adversely affects the Company’s reputation or the Executive’s ability to carry out the obligations of his or her
employment or services; 
 (vi) loss of any license or registration that is necessary for the Executive to
perform his or her duties for the Company; 

  

 (vii) failure to cooperate with the Company in any internal investigation or
administrative, regulatory or judicial proceeding, as determined in the reasonable judgment of the Company; 

(viii) any act or omission in violation or disregard of the Company’s policies, including but not limited to the
Company’s harassment and discrimination policies and Standards of Conduct then in effect, in such a manner as to cause significant loss, damage or injury to the Company’s property, reputation or employees; 

provided, however, that no act or failure to act on the Executive’s part shall be considered “willful” unless it is done, or omitted to be
done, by him or her in bad faith or without reasonable belief that his or her action or omission was in the best interests of the Company. Any act or failure to act (A) based upon authority given pursuant to a resolution duly adopted by the
Board of Directors of the Company, (B) implementing in good faith the advice of counsel for the Company or (C) that meets the applicable standard of conduct prescribed for indemnification or reimbursement or payment of expenses under the
By-laws of the Company or the laws of the state of its incorporation or the directors’ and officers’ liability insurance of the Company, in each case as in effect at the time Cause would otherwise arise, shall be conclusively presumed to
be done, or omitted to be done, in good faith and in the best interests of the Company. 
 (b) Change in Control. A
“Change in Control” shall be deemed to have occurred if, prior to the Executive’s Termination Date: 
 (i) any person (as that term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as in effect on the date of this Agreement)
(1) is or becomes the beneficial owner (as that term is used in Section 13(d) of the Exchange Act, and the rules and regulations promulgated thereunder, as in effect on the date of this Agreement) of 50% or more of the total fair market
value or total voting power of the Company (“Voting Securities”) or (2) acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person) ownership of the stock of the Company
possessing 30% or more of the Voting Securities, excluding, in each case, however, the following: (A) any acquisition directly from the Company, other than an acquisition by virtue of the exercise of a conversion privilege unless the security
being so converted was itself acquired directly from the Company; (B) any acquisition by the Company; (C) any acquisition by an employee benefit plan (or related trust) sponsored or maintained by the Company or any entity controlled by the
Company; (D) the acquisition of additional stock or voting power by a person considered to own more than 50% of the total fair market value or Voting Securities in the case of clause (1) of this clause (i) or by a person considered to
own more than 30% of the Voting Securities in the case of clause (2) of this clause (i) or (E) any acquisition pursuant to a transaction that complies with clauses (A), (B) and (C) of clause (iii) below; 

(ii) more than 50% of the members of the Board of Directors of the Company (the “Board”) shall, during a
12-month period, cease to be Continuing 

  
 2 

 
Directors (which term, as used herein, means the directors of the Company: (A) who were members of the Board on the date hereof; or (B) who subsequently became directors of the Company
and who were elected or designated to be candidates for election as nominees of the Board, or whose election or nomination for election by the Company’s stockholders was otherwise approved, by a vote of a majority of the Continuing Directors
then on the Board but shall not include, in any event, any individual whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14(a)-11 of Regulation 14A promulgated
under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board); or 
 (iii) the Company shall be merged or consolidated with, or, in any transaction or series of transactions, substantially all of the business or assets of the Company shall be sold or otherwise
acquired by, another corporation or entity unless, as a result thereof: (A) the stockholders of the Company immediately prior thereto shall beneficially own, directly or indirectly, at least 60% of the combined Voting Securities of the
surviving, resulting or transferee corporation or entity (including, without limitation, a corporation that as a result of such transaction owns the Company or all or substantially all of the assets of the Company , either directly or through one or
more subsidiaries) (“Newco”) immediately thereafter in substantially the same proportions as their ownership immediately prior to such corporate transaction; (B) no person beneficially owns (as such terms are used in Sections 13(d)
and 14(d) of the Exchange Act, and the rules and regulations promulgated thereunder (as in effect on the date hereof)), directly or indirectly, 30% or more of the combined Voting Securities of Newco immediately after such corporate transaction
except to the extent that such ownership of the Company existed prior to such corporate transaction, and (C) more than 50% of the members of the Board of Directors of Newco shall be Continuing Directors. 

(c) Change in Control Benefit. “Change in Control Benefit” shall refer to any special or enhanced benefits described in
Section 3 below to which the Executive may become entitled if his or her employment terminates for one of the reasons listed in Section 2(a) within the 24-month period following a Change in Control. 

(d) Code. “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(e) Disability. “Disability” shall mean a physical or mental illness that results in the Executive’s absence from
the full-time performance of his or her duties for 180 consecutive calendar days and within 30 days after the Notice of Termination is given to the Executive by the Company, the Executive shall not have returned to full-time performance of his or
her duties. 
 (f) Good Reason. Termination of employment by the Executive for Good Reason shall be deemed to have
occurred only if the Executive terminates his or her employment and provides a Notice of Termination to the Company prior to such date for any of the following reasons: 

  
 3 

 (i) a material change in the Executive’s duties, responsibilities and
status, or, in the event of a Change in Control, a material change in Executive’s reporting responsibilities, titles or offices as in effect at the time of a Change in Control; 

(ii) a material reduction in the Executive’s then current base salary; 

(iii) material reduction in the value of the benefits provided to the Executive (other than those plans or improvements
that have expired in accordance with their original terms); provided that Good Reason shall not exist to the extent such benefits are similarly reduced or eliminated with respect to similarly situated senior executives of the Company; 

(iv) after a Change in Control, the target bonus awarded by the Company’s Compensation and Stock Option Committee to
Executive under the Annual Executive Incentive Compensation Plan of the Company (“Incentive Plan”) subsequent to a Change in Control is materially less than such amount last awarded to Executive prior to a Change in Control; 

(v) after a Change in Control, the sum of the Executive’s base salary and amount paid to him or her as incentive
compensation under the Incentive Plan for the calendar year in which the Change in Control occurs or any subsequent year is materially less than the sum of the Executive’s base salary and the amount awarded (whether or not fully paid) to him or
her as incentive compensation under the Incentive Plan for the calendar year prior to the Change in Control or any subsequent calendar year in which the sum of such amounts was materially greater; 

(vi) the relocation of the offices at which Executive is employed to a location more than 35 miles away or the
Company requiring Executive to be based anywhere other than at a Company office within 35 miles of the offices at which the Executive is employed, except for required travel on Company business to an extent substantially consistent with
Executive’s position; 
 (vii) any failure of the Company to comply with and satisfy Section 8;

 (viii) any purported termination of the Executive’s employment by the Company which does not comply with
Section 1(g) below. For the avoidance of doubt, such purported termination shall not be effective, but shall constitute Good Reason entitling the Executive to terminate his or her employment in accordance with this Section 1(f);

 provided, further, that the Executive must provide written notice to the Company of the existence of Good Reason no later than 90 days after
its initial existence, the Company shall have a period of 30 days following its receipt of such written notice during which it may remedy in all material respects the Good Reason condition identified in such written notice, and the Executive must
terminate employment no later than two (2) years following the initial existence of the Good Reason condition identified in such written notice. 

  
 4 

 (g) Notice of Termination. “Notice of Termination” shall mean a written
notice sent by the Executive or the Company to the other party, describing the reasons for the termination of the Executive’s employment and including specific reference to the provision(s) of this Agreement at issue. Such Notice of Termination
must be provided by the party seeking to terminate the Executive’s employment within 90 days of the existence of either Cause or Good Reason, as applicable, and the party receiving the Notice of Termination shall be given 30 days to remedy such
situation (to the extent applicable). 
 (h) Termination Date. “Termination Date” shall mean: 

(i) in the case of Disability, 30 days after Notice of Termination is given, provided that the Executive shall not have
returned to the performance of his or her duties on a full-time basis during such 30-day period; 
 (ii) in the
case of Cause, the date on which Notice of Termination is given; 
 (iii) in the case of Good Reason, 30 days
after the Notice of Termination is given, provided that the Company has not either remedied the conditions giving rise to Good Reason or waived its right to do so; and 

(iv) in the event that employment is terminated for any other reason, the date on which the Executive ceases to perform
his or her duties for the Company; 
 provided, however, that, if within 30 days after any Notice of Termination is given, the receiving party
notifies the other party that a dispute exists concerning the reasons for such termination of employment, the Termination Date shall be the date finally determined, either by written agreement of the parties or by a final judgment, order or decree
of court of competent jurisdiction (the time for appeal having expired and no appeal having been perfected), to be the date that the Executive’s employment terminated; provided further, however, that if such dispute is resolved in favor of the
Company, the Termination Date shall be the date determined under clauses (i) through (iv) of this Section 1(h). 

2. Entitlement to Benefits. The Executive shall be entitled to the benefits described in Section 3 below if: 

(a) the Executive’s employment is terminated either by the Company for reasons other than Disability or Cause or by the Executive for
Good Reason; provided, however, that, in order for the Executive to be eligible for any Change in Control Benefits, such termination of employment must occur within 24 months after a Change in Control of the Company; 

(b) the Executive’s Termination Date occurs while this Agreement is in effect; and 

  
 5 

 (c) a Notice of Termination is provided in a timely manner (as described in
Section 1(g)) prior to the Executive’s Termination Date by the Company (in the case of termination other than for Disability or Cause) or the Executive (in the case of termination for Good Reason). 

Executive’s employment shall be deemed to have terminated for Cause if, after the Executive’s Termination Date, facts and circumstances are
discovered that would have justified a termination for Cause. In such event, the Company shall immediately cease any and all payments and benefits being paid or provided to the Executive under Section 3 and the Executive shall repay to the
Company within thirty (30) days all amounts previously paid to him or her pursuant to Section 3. 
 Nothing in this Agreement is
intended to create or imply a promise or contract of employment for a specified term and either Executive or the Company may terminate the employment relationship at any time, with or without Cause or Good Reason, and with or without notice;
provided, however, that the Executive shall not be entitled to any benefits under this Agreement in the event his or her employment is terminated by the Company for Disability or Cause, by the Executive other than for Good Reason or following the
Executive’s death or the expiration of this Agreement. This Agreement shall have no effect on any obligations that the Company may have to the Executive if his or her employment terminates under circumstances not described herein. 

3. Benefits Upon Termination of Employment. Notwithstanding the provisions of Section 2 above, in order to receive the
benefits described in paragraphs (b), (c), (d) and (e) below, the Executive must timely deliver and not revoke an executed release of legal claims against the Company and its affiliates within the timelines set forth therein. 

(a) Accrued Pay. The Company shall pay the Executive any base salary or vacation accrued but unpaid through his or her Termination
Date. 
 (b) Severance Pay. The Company shall pay severance benefits to the Executive equal to the product of one and
one-half (1.5) times the sum of the following amounts, subject to any applicable limitations in Sections 3(f) and 3(g) below: 
 (i) his or her annual base salary as in effect on the Effective Date, or, if applicable, the date of a Change in Control, plus 

(ii) his or her target annual bonus under the Incentive Plan in effect in the calendar year in which the Termination Date
occurs, plus 
 (iii) the amount that would have been required to be allocated to the Executive’s account
(assuming that he elected the maximum employee contribution) for the year immediately preceding the year in which the Termination Date occurs under the Company’s 401(k) retirement plan, including the Company 401(k) matching contribution, and
the profit-sharing provisions of the Company’s Supplemental Plan (the “Supplemental Plan”); 

  
 6 

 Such severance amounts described above shall be paid to the Executive in regular
installments through the Company’s normal payroll process and on the Company’s normal payroll dates commencing within 90 days following his or her Termination Date; provided, however, that if such 90-day period begins in a first taxable
year and ends in a second taxable year, such severance amounts shall commence no earlier than the first payroll date of the second taxable year. 
 Notwithstanding anything to the contrary in this Section 3(b), for purposes of calculating a Change in Control Benefit, the multiplier in Section 3(b) above shall be changed to two (2) and
the severance benefit shall be paid to the Executive in a single lump sum payment within 30 days following the Executive’s Termination Date; provided, however, that if such 30-day period begins in a first taxable year and ends in a second
taxable year, such lump sum payment shall be paid to the Executive in the second taxable year. 
 (c) Continued Benefits
Coverage. The Company shall maintain for the Executive’s benefit all employee life, health, accident, and medical plan coverage(s) that Executive was receiving immediately prior to his or her Termination Date, provided that his or her
continued participation is allowed under the terms of such plans. The Company shall maintain such coverage(s) following the Executive’s Termination Date for 18 months, or, if the Executive is entitled to a Change in Control Benefit, two
(2) years. With respect to any continued health coverage (medical, dental and vision), the Executive shall be required to pay the applicable active employee rate of coverage for similar coverage, and such coverage shall run concurrent with
coverage required to be provided under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”). If the Company continues to provide the continued health coverage described in this Section 3(c) after the applicable period
of COBRA coverage would have otherwise expired, the Executive may be taxed on the value of such coverage. No other welfare or fringe benefits shall be provided except as specifically provided in this Section 3(c). 

(d) Incentive Compensation. The following amounts shall become payable to the Executive following his or her Termination Date, as
of the date that annual incentive awards are normally paid by the Company: 
 (i) any unpaid amounts awarded to
the Executive as incentive compensation under the Incentive Plan for the calendar year immediately preceding the year in which the Termination Date occurs; and 
 (ii) an amount equal to the award the Executive would have received under the Incentive Plan based upon actual Company performance for the calendar year in which the Termination Date occurs, prorated for
the portion of the calendar year during which the Executive was employed. 
 (e) Unvested Retirement Savings Benefits. If
the Executive is entitled to a Change in Control Benefit, the Company shall pay to the Executive as additional severance pay in a lump sum an amount, if any, equal to the nonvested portion of his or her account balances under the Company’s
401(k) retirement plan and the defined contribution plan of any affiliate of the Company in which there is maintained for him or her an account balance which is not fully 

  
 7 

 
vested. Such payment shall be paid to the Executive in a lump sum payment within 30 days following the Executive’s Termination Date; provided, however, that if such 30-day period begins in a
first taxable year and ends in a second taxable year, such lump sum payment shall be paid to the Executive in the second taxable year. 
 (f) Tax Withholding. The Company may withhold from any benefits payable under this Agreement any applicable federal, state, city or other taxes as required by law. 

(g) Time of Payment for Specified Employees. Notwithstanding any provision of this Section 3 to the contrary, if the
Executive is a “specified employee” of the Company (as defined in Section 409A of the Code), amounts that would otherwise have been paid to or on behalf of the Executive under the foregoing provisions of this Section 3 (but
excluding amounts described in paragraphs 3(a) and 3(c) above) during the six-month period immediately following the Termination Date shall be paid on the first regular payroll date immediately following the six-month anniversary of the Termination
Date. 
 (h) No Duty to Mitigate. The Executive shall not be required to mitigate the amount of any payment provided for
in this Section 3 by seeking other employment or otherwise, nor shall the amount of any payment provided for in this Section 3 be reduced by any compensation earned by the Executive as the result of employment by another employer after the
Termination Date or by any other compensation. 
 (i) No Other Severance Benefits. This Agreement sets forth the entire
agreement of the parties hereto in respect of the subject matter contained herein and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer,
employee or representative of the Company, its affiliates or any of their predecessors, including but not limited to any severance pay program or other documents covering salaried or executive employees generally maintained by the Company, any of
its affiliates or subsidiaries. To the extent severance payments or benefits are required under any applicable local law or otherwise, benefits payable under this Agreement shall be reduced to the extent of any such severance payments or benefits
(including, but not limited to, any laws requiring payment in lieu of notice upon the Executive’s termination of employment). 
 4. Certain Reductions Due to Section 280G. Notwithstanding any provision of this Agreement to the contrary, in the event it shall be (or is subsequently) determined that any payment,
distribution or acceleration of vesting by the Company to or for the benefit of the Executive (whether pursuant to the terms of this Agreement or otherwise (any such payment, distribution or acceleration of vesting being referred to as a
“Payment”) would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Change in Control Benefit payable to the Executive under this Agreement shall be reduced (or appropriately
adjusted) to an amount that is one dollar less than the smallest amount that would give rise to the Excise Tax (the “Reduced Amount”) if such Reduced Amount would be greater than the net after-tax proceeds (taking into account both the
Excise Tax and any interest or penalties payable with respect to the Excise Tax) of the unreduced Change in Control Benefit payable to the Executive. If the Change in Control Benefit is required to be reduced pursuant to this Section 4, there
shall be no discretion in the ordering of the Payments payable under this Agreement so 

  
 8 

 
reduced, and such reductions shall be applied in the order which results in the best economic benefit to Executive; and to the extent such ordering of reductions is economically equivalent, such
Payments shall be reduced on a pro rata basis. 
 5. Section 409A. This Agreement is intended to comply with the
requirements of Section 409A of the Code and shall be interpreted and construed consistently with such intent. The payments to the Executive pursuant to this Agreement are also intended to be exempt from Section 409A of the Code to the
maximum extent possible, under either the separation pay exemption pursuant to Treasury regulation §1.409A-1(b)(9)(iii) or as short-term deferrals pursuant to Treasury regulation §1.409A-1(b)(4), and for this purpose each payment shall
constitute a “separately identified” amount within the meaning of Treasury Regulation §1.409A-2(b)(2). Notwithstanding anything in this Agreement to the contrary, in the event that any amounts payable (or benefits provided) under this
Agreement are subject to the provisions of Section 409A of the Code, to the extent determined necessary, the parties agree to amend this Agreement in the least restrictive manner necessary to avoid imposition of any additional tax or income
recognition on the Executive under Section 409A of the Code, the final Treasury Regulations and other Internal Revenue Service guidance thereunder (“409A Penalties”); provided, that in no event shall the Company be responsible for any
409A Penalties that arise in connection with any amounts payable under this Agreement. In addition, to the extent necessary to comply with Section 409A of the Code, references to termination of employment (and similar phrases) in this Agreement
shall be interpreted in a manner that is consistent with the term “separation from service” under Section 409A(a)(2)(A)(i) of the Code and final Treasury Regulations and other Internal Revenue Service guidance thereunder. 

 

	 	6.	Restrictive Covenants. 

(a) Confidential Information. The Executive acknowledges that he or she will have access to highly confidential information of the
Company and its affiliates, including, but not limited to: financial information, supply and service information, marketing information, personnel data, customer lists, business and financial plans and strategies, and product costs, sources and
pricing. The Company and the Executive consider it imperative that all such information (“Confidential Trade Secrets”) be held in complete confidence and trust. Accordingly, the Executive agrees that, notwithstanding any other provision of
this Agreement to the contrary, during and following the Executive’s Termination Date with the Company, regardless of the reasons that such employment might end, the Executive will: 

(i) hold all Confidential Trade Secrets in confidence and not discuss, communicate, disclose or transmit to others, or
make any unauthorized copy of or use the Confidential Trade Secrets in any capacity, position or business unrelated to the Company; 
 (ii) use the Confidential Trade Secrets only in furtherance of proper Company employment related business reasons; and 

(iii) take all reasonable action that the Company deems necessary and appropriate to prevent unauthorized use or
disclosure of or to protect the Confidential Trade Secrets. 

  
 9 

 Notwithstanding the foregoing, it is understood and agreed that the Executive’s obligations under this
Section 6(a) do not extend to any knowledge or information which is or may become available to the public or to competitors other than by disclosure by the Executive in breach of this Agreement nor to any information the Executive may learn or
develop independent of the Confidential Trade Secrets, nor to disclosure compelled by judicial or administrative proceeding after the Executive diligently tries to avoid each disclosure and affords the Company the opportunity to obtain assurance
that compelled disclosures will receive confidential treatment. 
 (b) Loyalty; Non-Solicitation. The Executive further
acknowledges that the loyalty and dedicated service of the Company’s and its affiliates’ employees is critical to the Company’s business. Accordingly, the Executive agrees that during and for a period of twelve (12) months after
the Executive’s Termination Date, regardless of the reasons for the termination of employment, he or she will not, without the prior written consent of the Company, induce or attempt to induce any employee or agency representative of the
Company or any of its affiliates to leave the employment or representation of the Company or of any affiliate. The Executive also agrees that during and after his or her employment, he will not take any action, or make any statements, that discredit
or disparage the Company or its affiliates, or its or their officers, directors, employees or products. The Company agrees that it will not take any action or make any statements during and after Executive’s employment that discredit or
disparage the Executive. The two preceding sentences shall not apply to statements made in papers filed in good faith with a court of law in connection with a lawsuit between the Executive and the Company or any of its affiliates. 

(c) Non-Competition. The Executive acknowledges that the Company and its affiliates have invested time and money in establishing
or planning to establish one or more aspects of its business in major Beam markets, including but not limited to the United States, Australia/Southeast Asia/India/Brazil, Canada, Mexico and Europe/Middle East/Africa (the “Competitive
Markets”). Therefore, the Executive agrees that during his or her employment by the Company and for a period of 12 months after the Executive’s Termination Date, the Executive will not: 

(i) directly or indirectly, individually engage in nor be competitively employed or retained by, or render any competing
services for, or be financially interested in, any firm or corporation engaged in any business in the Competitive Markets which competes with any business in which the Company or any of its affiliates was engaged during the two-year period preceding
the Executive’s Termination Date, including, but not limited to any business in which, during such two-year period, the Executive was involved in the Company’s or any affiliate’s planning to enter such business. Notwithstanding the
foregoing, this restriction shall not apply to: 
 (A) the purchase by the Executive of stock not to exceed 5%
of the outstanding shares of capital stock or any corporation whose securities are listed on any national securities exchange; or 
 (B) the employment of the Executive by a non-competitive subsidiary or non-competitive affiliated entity of a competitor of the Company upon the Company’s written consent, which consent shall not be
unreasonably withheld. 

  
 10 

 (ii) solicit business from nor directly or indirectly cause others to
solicit business that competes with the Company’s line of products from any entities which have been customers of the Company during the Executive’s employment or which were targeted as potential customers during the twelve
(12) months preceding the Executive’s Termination Date; 
 provided, however, that the provisions of this Section 6(c) shall not
apply if the Executive’s Termination Date occurs after a Change in Control. 
 (d) Remedies. The Executive
recognizes and agrees: 
 (i) that the covenants and restrictions in paragraphs (a), (b) and (c) of
this Section 6 are reasonable and valid and all defenses to the strict enforcement of such sections by the Company are waived by the Executive to the full extent permitted by law. In the event, however, that a court of competent jurisdiction
should determine in any case that the enforcement of any provision contained in such paragraphs would not be reasonable, it is intended that enforcement of a provision which is determined by such court to be reasonable shall be given effect; and

 (ii) that a breach of the covenants and restrictions in paragraphs (a), (b) or (c) of this
Section 6 would result in irreparable harm to the Company which could not be compensated by money damages alone. Accordingly, the Executive agrees that should there be a breach of any or all of these provisions or a threatened breach, the
Company shall be entitled to cease paying amounts under Section 3 and to offset any amounts it owes to Executive against any damage that it has suffered as a result of the breach of any of the covenants and restrictions in paragraphs (a),
(b) or (c) of this Section 6 and, in addition to its other remedies, to an order enjoining any such breach or threatened breach without bond. In addition, the Executive agrees that, in the event he or she breaches any of the covenants
or restrictions of paragraphs (a), (b) or (c) of this Section 6, he will promptly repay to the Company upon demand any amounts paid to him or her pursuant to Section 3. The Executive further agrees that if the Company prevails in
any action to enforce these provisions, he or she will reimburse the Company for its attorney fees and costs incurred in pursuing such action. 

The Company agrees that it will seek enforcement of paragraphs (a), (b) and (c) of this Section 6 only in a good faith, reasonable manner
and will not seek to enforce such sections solely for malicious and punitive reasons. 
 7. Disputes. In the event that
the Executive prevails in any action to obtain or enforce any rights under this Agreement, the Company shall pay the cost of legal fees and expenses incurred by Executive in such action, which payment shall be made directly to the provider of
services within the time period required by Section 409A of the Code; provided, 

  
 11 

 
however that the Executive shall be required to deliver and not revoke an executed release of claims in the form attached hereto as Exhibit A (as such release may be updated from time to time to
reflect legal requirements). If a dispute arises concerning the Executive’s entitlement to benefits under this Agreement following a Change in Control, the Company shall continue to pay Executive’s full base salary through the date finally
determined to be his or her Termination Date. 
 8. Successors; Binding Agreement. 

(a) The Company shall require any successor to all or substantially all of its business or assets (whether direct or indirect, by
purchase, merger, consolidation or otherwise), and any parent company thereof, to expressly assume and agree to perform the Company’s obligations under this Agreement. 
 (b) This Agreement shall not be assignable by the Executive except by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive and his
or her personal or legal representatives and successors in interest. 
 9. Term. Unless otherwise earlier terminated in
writing by both parties, this Agreement shall be effective for the three (3) year period commencing on the Effective Date. At the close of such three (3) year period and on each subsequent third anniversary of the Effective Date, the
Agreement shall automatically renew for an additional three (3) year period unless either party hereto shall notify the other party in writing of its intent not to renew the Agreement no less than thirty (30) days prior to the expiration
of the pending term; provided, however, that if within six (6) months following the non-renewal of the Agreement by the Company, the Company executes a definitive agreement which would lead to a Change in Control, then notwithstanding any other
term or provision of this Agreement, this Agreement shall be deemed not to have been terminated and will be effective in accordance with its terms through and including the date of such Change in Control (or the date on which such definitive
agreement is terminated, if earlier); and provided further, that if a Change in Control occurs during the term of this Agreement, the Agreement shall remain in effect for no less than 24 months following such Change in Control. Notwithstanding the
termination or expiration of this Agreement, the Restrictive Covenants provisions of Section 6 hereof shall remain in full force and effect as provided above. 
 10. Notice. Any notice, demand or other communication required or permitted under this Agreement shall be effective only if it is in writing and delivered personally or sent by registered or
certified mail, return receipt requested, postage prepaid, addressed as follows: 
  

	
	If to the Company:
	
	Beam Inc.
	510 Lake Cook Road
	Deerfield, Illinois 60015
	Attention:    General Counsel

  
 12 

  

	
	If to the Executive:
	
	At the address most recently on file with the Company

 or to such other address as either party may designate by written notice to the other and shall be deemed to have been
given as of the date so personally delivered or mailed. 
 11. Miscellaneous. 

(a) This Agreement cannot be modified or any term or condition waived in whole or in part except by a writing signed by the party against
whom enforcement of the modification or waiver is sought. 
 (b) This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware. 
 (c) No waiver by either party at any time of any breach of this Agreement by the
other party shall be deemed a waiver of such provisions or conditions at any prior or subsequent time. 
 (d) The headings in
this Agreement are included for convenience and shall not affect the meaning or interpretation of this Agreement. 
 (e) The
invalidity or unenforceability of one or more provisions of this Agreement shall not affect the enforceability any other provision of this Agreement. 
 (f) This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, and such counterparts will together constitute one Agreement. 

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by a duly authorized officer and attested to and the Executive
has set his or her hand as of the date first above written. 
  

			
	BEAM INC.
		
	By:	 	 
	Name:	 	 
	Its:	 	 

  

			
	 ATTEST:

		
		 	 

  

			
	EXECUTIVE
		
		 	 

  
 13Second Supplemental Indenture

 Exhibit 4.1 
 EXECUTION COPY 
 SECOND SUPPLEMENTAL INDENTURE 

Second Supplemental Indenture (this “Second Supplemental Indenture”), dated as of February 28, 2012, among Energy
Future Intermediate Holding Company LLC, a Delaware limited liability company (“EFIH”), and EFIH Finance Inc., a Delaware corporation (“EFIH Finance” and, together with EFIH, the “Issuer”), and The
Bank of New York Mellon Trust Company, N.A., as Trustee. 
 W I T N E S S E T H 

WHEREAS, the Issuer has heretofore executed and delivered to the Trustee an Indenture, dated as of April 25, 2011 (the
“Existing Indenture”), providing for the issuance of $406,392,000 in aggregate principal amount of 11% Senior Secured Second Lien Notes due 2021 (the “Initial 2021 Second Lien Notes”) and a First Supplemental
Indenture, dated as of February 6, 2012 (the “First Supplemental Indenture” and, together with the Existing Indenture, the “Indenture”), providing for the issuance of $800,000,000 in aggregate principal amount
of 11.750% Senior Secured Second Lien Notes due 2022 (the “Initial 2022 Second Lien Notes”); 
 WHEREAS, on
February 6, 2012, the Issuer issued and sold the Initial 2022 Second Lien Notes; 
 WHEREAS, Section 2.01(d) of the
Indenture provides for the issuance from time to time of Additional 2022 Second Lien Notes by the Issuer; 
 WHEREAS, the Issuer
desires to issue $350,000,000 aggregate principal amount of Additional 2022 Second Lien Notes on the date hereof (the “New Additional Notes”); 
 WHEREAS, the New Additional Notes shall be consolidated with, and form a single series and be fully fungible with, the Initial 2022 Second Lien Notes and, along with the Initial 2022 Second Lien Notes,
will form a separate series of Notes but be treated as a single class with the Initial 2021 Second Lien Notes; 
 WHEREAS,
Section 9.01(9) of the Indenture provides that the Issuer and the Trustee may amend or supplement the Indenture without the consent of any Holder to provide for the issuance of Additional 2022 Second Lien Notes that constitute Required Debt in
accordance with the Indenture so long as such Additional 2022 Second Lien Notes are issued in compliance with the provisions of the Indenture; 
 WHEREAS, the New Additional Notes shall be issued in compliance with the Indenture; 

WHEREAS, all conditions necessary to authorize the execution and delivery of this Second Supplemental Indenture and to make this Second
Supplemental Indenture valid and binding have been complied with or have been done or performed; and 
 WHEREAS, pursuant to
Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Second Supplemental Indenture. 

 NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of all Persons who are now or hereafter become Holders of the New Additional Notes as follows: 

1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to
them in the Indenture. 
 2. ADDITIONAL NOTES. Pursuant to this Second Supplemental Indenture, the
New Additional Notes are hereby designated as “Additional 2022 Second Lien Notes” under the Indenture, and are being originally issued by the Issuer on the date hereof in an aggregate principal amount of $350,000,000, which shall increase
the aggregate principal amount of, and shall be consolidated and form a single series with, the Initial 2022 Second Lien Notes. The New Additional Notes issued hereunder shall be treated as a single class with the Initial 2022 Second Lien Notes for
all purposes under the Indenture, including, without limitation, for purposes of waivers, amendments, redemptions and offers to purchase. Unless the context requires otherwise, references to “2022 Second Lien Notes” or “Notes”
for all purposes under the Indenture, as supplemented by this Second Supplemental Indenture, shall include the New Additional Notes. The New Additional Notes shall be issued in global form in minimum denominations of $2,000 and integral multiples of
$1,000 in excess thereof in substantially the form of Exhibit A hereto. The terms and provisions of the New Additional Notes set forth in Exhibit A hereto shall constitute and are expressly made a part of this Second Supplemental
Indenture. 
 3. NO EXCHANGE OF EXISTING NOTES
REQUIRED. The execution of this Second Supplemental Indenture shall not require the exchange of or modification to the certificates representing Notes existing prior to the date hereof. 

4. GOVERNING LAW. THIS SECOND SUPPLEMENTAL
INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE
LAWS OF THE STATE OF NEW YORK. 
 5. RATIFICATION, CONFIRMATION AND PRESERVATION OF INDENTURE. Except as expressly supplemented hereby, the
Indenture continues in full force and effect and is in all respects confirmed, ratified and preserved and the provisions thereof shall be applicable to the New Additional Notes and this Second Supplemental Indenture. Upon the execution and delivery
of this Second Supplemental Indenture by the Issuer and the Trustee, this Second Supplemental Indenture shall form a part of the Indenture for all purposes, and the Issuer, the Trustee and every Holder of Notes heretofore or hereafter authenticated
and delivered shall be bound hereby. Any and all references to the “Indenture,” whether within the Indenture or in any notice, certificate or other instrument or document, shall be deemed to include a reference to this Second Supplemental
Indenture (whether or not made), unless the context shall otherwise require. 
 6. INDENTURE AND
SECOND SUPPLEMENTAL INDENTURE CONSTRUED TOGETHER. This Second Supplemental Indenture is an indenture supplemental to the Indenture, and the Indenture and this Second
Supplemental Indenture shall henceforth be read and construed together for all purposes. 

  
 -2-

 7. BENEFITS OF SECOND
SUPPLEMENTAL INDENTURE. Nothing in this Second Supplemental Indenture, the Indenture or the Notes, express or implied, shall give to any Person other than the parties hereto and thereto and their successors hereunder
and thereunder, any Paying Agent, any Registrar and the Holders, any benefit of any legal or equitable right, remedy or claim under the Indenture, this Second Supplemental Indenture or the Notes. 

8. SUCCESSORS. All agreements of the Issuer in this Second Supplemental Indenture shall bind its successors. All
agreements of the Trustee in this Second Supplemental Indenture shall bind its successors. 
 9. THE
TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Second Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals
are made solely by the Issuer. 
 10. COUNTERPARTS. The parties may sign any number of copies of this Second
Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. 
 11.
EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof. 
 [Remainder of Page Left Intentionally Blank] 

  
 -3-

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be
duly executed and attested, all as of the date first above written. 
  

			
	ENERGY FUTURE INTERMEDIATE HOLDING COMPANY LLC
		
	By:	 	/s/ Anthony R. Horton
		 	Name: Anthony R. Horton
		 	Title: Senior Vice President and Treasurer
	
	EFIH FINANCE INC.
		
	By:	 	 /s/ Anthony R. Horton

		 	 Name: Anthony R. Horton

		 	 Title: Senior Vice President and Treasurer

	
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	/s/ Julie Hoffman-Ramos
		 	 Name: Julie Hoffman-Ramos

		 	 Title: Vice President

 [Signature Page to Second Supplement Indenture] 

 EXHIBIT A 
 [Face of 2022 Second Lien Note] 
 [Insert the Global Note Legend, if applicable pursuant to the
provisions of the Indenture] 
 [Insert the Private Placement Legend, if applicable pursuant to the provisions of the Indenture]

 [Insert the Tax Legend, if applicable pursuant to the provisions of the Indenture] 

CUSIP: [            ] 1 

ISIN: [            ] 

[RULE 144A] [REGULATION S] GLOBAL NOTE 
 11.750% Senior Secured Second Lien Notes due 2022 
  

			
	No.[R-[    ][S-[    ]]	  	[$            ]

 ENERGY FUTURE INTERMEDIATE HOLDING COMPANY LLC 

EFIH FINANCE INC. 
 promise
to pay to CEDE & CO. or registered assigns, the principal sum [set forth on the Schedule of Exchanges of Interests in the Global Note attached hereto] [of [            ] United
States Dollars ($[            ])] on March 1, 2022. 
 Interest Payment Dates:
March 1 and September 1, commencing September 1, 2012 
 Record Dates: February 15 and August 15 

[SIGNATURE PAGE FOLLOWS] 
  

 

					
	1	  	Rule 144A Note CUSIP:	  	29269Q AD9
		  	Rule 144A Note ISIN:	  	US29269QAD97
		  	Regulation S Note CUSIP:	  	U29197 AB3
		  	Regulation S Note ISIN:	  	USU29197AB36

  
 A-1

 IN WITNESS HEREOF, the Issuer has caused this instrument to be duly executed. 

Dated:             , 20         

 

			
	 ENERGY FUTURE INTERMEDIATE
     HOLDING COMPANY LLC

		
	By:	 	 
		 	Name:
		 	Title:

  

			
	EFIH FINANCE INC.
		
	By:	 	 
		 	Name:
		 	Title:

 This is one of the 2022 Second Lien Notes referred to in the within-mentioned Indenture: 

 

			
	 THE BANK OF NEW YORK MELLON
 TRUST COMPANY, N.A., as Trustee

		
	By:	 	 
		 	Authorized Signatory

 Dated:             ,
20         
 SIGNATURE PAGE TO GLOBAL [144A] [REGULATION S] 2022 SECOND LIEN NOTE

 [Back of 2022 Second Lien Note] 

This 2022 Second Lien Note is one of a duly authorized series of notes of the Issuer designated as the “11.750% Senior Secured
Second Lien Notes due 2022” (the “2022 Second Lien Notes”), originally issued in an aggregate principal amount of $800,000,000 on February 6, 2012, and, as a result of a further issuance of $350,000,000 aggregate principal
amount of 2022 Second Lien Notes on February 28, 2012, now issued in an aggregate principal amount of $1,150,000,000, under the Indenture referred to below. 
 Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 

(1) INTEREST. Energy Future Intermediate Holding Company LLC, a Delaware limited liability company
(“EFIH”), and EFIH Finance Inc., a Delaware corporation (collectively, the “Issuer”), promise to pay interest on the principal amount of this 2022 Second Lien Note at 11.750% per annum from February 6,
2012 until maturity and shall pay Additional Interest, if any, payable pursuant to the Registration Rights Agreement referred to below. The Issuer will pay interest (including Additional Interest, if any) semi-annually in arrears on March 1 and
September 1 of each year, commencing on September 1, 2012, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment Date”) without interest accruing on the amount then so
payable from such day that is not a Business Day until such Business Day. Interest on the 2022 Second Lien Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from and including
February 6, 2012. The Issuer will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at the interest rate on the 2022 Second Lien
Notes; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (including Additional Interest, if any) (without regard to any applicable grace periods) from time to time
on demand at the interest rate on the 2022 Second Lien Notes. Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months. 
 (2) METHOD OF PAYMENT. The Issuer will pay interest on the 2022 Second Lien Notes (including Additional Interest, if any) to the Persons
who are registered Holders of 2022 Second Lien Notes at the close of business on the February 15 and August 15 (whether or not a Business Day), as the case may be, next preceding the Interest Payment Date, even if such 2022 Second Lien
Notes are canceled after such Record Date and on or before such Interest Payment Date, except as provided in Section 2.12 of the Indenture with respect to defaulted interest. Payment of interest (including Additional Interest, if any) may be
made by check mailed to the Holders at their addresses set forth in the register of Holders; provided that payment by wire transfer of immediately available funds will be required with respect to principal of, premium, if any, and interest
(including Additional Interest, if any) on, all Global Notes and all other 2022 Second Lien Notes the Holders of which shall have provided wire transfer instructions to the Issuer or the Paying Agent. Such payment shall be in such coin or currency
of the United States of America as at the time of payment is legal tender for payment of public and private debts. 
 (3)
PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company, N.A., the Trustee under the Indenture, will act as Paying Agent and Registrar. The
Issuer may change any Paying Agent or Registrar without notice to the Holders. The Issuer or any of its Subsidiaries may act in any such capacity. 

  
 A-3

 (4) INDENTURE. The Issuer issued the 2022 Second Lien
Notes under an Indenture, dated as of April 25, 2011 (the “Existing Indenture”), between the Issuer and the Trustee, as supplemented by the First Supplemental Indenture, dated as of February 6, 2012, between the Issuer and
the Trustee, and the Second Supplemental Indenture, dated as of February 28, 2012 (the Existing Indenture as so supplemented, the “Indenture”), between the Issuer and the Trustee. This 2022 Second Lien Note is one of a duly
authorized issue of notes of the Issuer designated as its 11.750% Senior Secured Second Lien Notes due 2022. The Issuer shall be entitled to issue Additional 2022 Second Lien Notes pursuant to Sections 2.01, 4.09 and 4.12 of the Indenture. The 2021
Second Lien Notes (including any Exchange Notes issued in exchange therefor) and the 2022 Second Lien Notes (including any Exchange Notes issued in exchange therefor) (collectively referred to herein as the “Notes”) are separate
series of Notes, but shall be treated as a single class of securities under the Indenture, unless otherwise specified in the Indenture. In addition, the Notes will be treated along with certain other securities designated as Junior Lien Debt of the
Issuer as a single class for amendments and waivers and for taking certain other actions. The terms of the 2022 Second Lien Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of
1939, as amended (the “Trust Indenture Act”). The 2022 Second Lien Notes are subject to all such terms, and Holders are referred to the Indenture and the Trust Indenture Act for a statement of such terms. To the extent any provision
of this 2022 Second Lien Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 
 (5) OPTIONAL REDEMPTION. 
 (a)
Except as set forth below, the Issuer will not be entitled to redeem 2022 Second Lien Notes at its option prior to March 1, 2017. 
 (b) At any time prior to March 1, 2017, the Issuer may redeem the 2022 Second Lien Notes, in whole or in part, upon not less than 30 nor more than 60 days’ prior notice mailed by first class
mail to the registered address of each Holder of 2022 Secured Lien Notes or otherwise delivered in accordance with the procedures of DTC, at a redemption price equal to 100% of the principal amount of the 2022 Second Lien Notes redeemed, plus
the Applicable Premium, plus accrued and unpaid interest (including Additional Interest, if any) to, the applicable date of redemption (the “Redemption Date”), subject to the right of Holders of 2022 Second Lien Notes of record on
the relevant Record Date to receive interest due on the relevant Interest Payment Date. 
 (c) From and after March 1,
2017, the Issuer may redeem the 2022 Second Lien Notes, in whole or in part, upon not less than 30 nor more than 60 days’ prior notice mailed by first class mail to the registered address of each Holder of 2022 Second Lien Notes or otherwise
delivered in accordance with the procedures of DTC, at the redemption prices (expressed as percentages of the principal amount of the 2022 Second Lien Notes to be redeemed) set forth below, plus accrued and unpaid interest (including
Additional Interest, if any) to the applicable Redemption Date, subject to the right of Holders of 2022 Second Lien Notes of record on the relevant Record Date to receive interest due on the relevant Interest Payment Date, if redeemed during the
twelve-month period beginning on March 1 of each of the years indicated below: 

  
 A-4

  

					
	Year	  	Percentage	 
	 2017
	  	 	105.875	% 
	 2018
	  	 	103.917	% 
	 2019
	  	 	101.958	% 
	 2020 and thereafter
	  	 	100.000	% 

 (d) Prior to March 1, 2015, the Issuer may, at its option, on one or more occasions, redeem up to
35% of the aggregate principal amount of all 2022 Second Lien Notes at a redemption price equal to 111.750% of the aggregate principal amount thereof, plus accrued and unpaid interest (including Additional Interest, if any) to the Redemption
Date, subject to the right of Holders of 2022 Second Lien Notes of record on the relevant Record Date to receive interest due on the relevant Interest Payment Date, with the net cash proceeds of one or more Equity Offerings; provided that at
least 50% of the sum of the original aggregate principal amount of Initial 2022 Second Lien Notes and any Additional 2022 Second Lien Notes issued under the Indenture remains outstanding immediately after the occurrence of each such redemption;
provided further that each such redemption occurs within 90 days of the date of closing of each such Equity Offering. Notice of any redemption upon any Equity Offerings may be given prior to the redemption thereof, and any such
redemption or notice may, at the Issuer’s discretion, be subject to one or more conditions precedent, including, but not limited to, completion of the related Equity Offering. 

(e) If the Issuer redeems less than all of the outstanding 2022 Second Lien Notes, the Trustee shall select the 2022 Second Lien Notes to
be redeemed in the manner described under Section 3.02 of the Indenture. 
 (f) Any redemption pursuant to this paragraph 5
shall be made pursuant to the provisions of Sections 3.01 through 3.06 of the Indenture. 
 (6) MANDATORY
REDEMPTION. The Issuer shall not be required to make mandatory redemption or sinking fund payments with respect to the 2022 Second Lien Notes. 

(7) NOTICE OF REDEMPTION. Subject to Section 3.03 of the
Indenture, notice of redemption will be mailed by first-class mail at least 30 days but not more than 60 days before the Redemption Date (except that redemption notices may be mailed or delivered more than 60 days prior to a Redemption Date if the
notice is issued in connection with Article 8 or Article 12 of the Indenture) to each Holder whose 2022 Second Lien Notes are to be redeemed at its registered address or otherwise delivered in accordance with the procedures of DTC. 2022 Second Lien
Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000 in excess thereof, unless all of the 2022 Second Lien Notes held by a Holder are to be redeemed. On and after the Redemption Date interest ceases
to accrue on 2022 Second Lien Notes or portions thereof called for redemption. 

  
 A-5

 (8) OFFERS TO REPURCHASE.

 (a) If a Change of Control occurs, the Issuer shall make an offer (a “Change of Control Offer”) to each
Holder to purchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of each Holder’s Notes at a purchase price equal to 101% of the aggregate principal amount thereof, plus accrued and unpaid interest
(including Additional Interest, if any) to the date of purchase (the “Change of Control Payment”), subject to the right of Holders of Notes of record on the relevant Record Date to receive interest due on the relevant Interest
Payment Date. The Change of Control Offer shall be made in accordance with Section 4.14 of the Indenture. 
 (b) If EFIH or
any of its Restricted Subsidiaries consummates an Asset Sale (other than an Asset Sale of Collateral or other Oncor-related Assets), within 10 Business Days of each date that the aggregate amount of Excess Proceeds exceeds $200.0 million, EFIH shall
make an offer to all Holders of the Notes, and if required or permitted by the terms of any Senior Indebtedness, to the holders of such Senior Indebtedness (an “Asset Sale Offer”), to purchase the maximum aggregate principal amount
of the Notes and such Senior Indebtedness that is a minimum of $2,000 or an integral multiple of $1,000 in excess thereof that may be purchased out of the Excess Proceeds at an offer price in cash in an amount equal to 100% of the principal amount
thereof, plus accrued and unpaid interest (including Additional Interest, if any) to the date fixed for the closing of such offer, in accordance with the procedures set forth in the Indenture. To the extent that the aggregate amount of Notes
and such Senior Indebtedness tendered pursuant to an Asset Sale Offer is less than the Excess Proceeds, EFIH may use any remaining Excess Proceeds for general corporate purposes, subject to other covenants contained in the Indenture. If the
aggregate principal amount of Notes or such Senior Indebtedness surrendered by such holders thereof exceeds the amount of Excess Proceeds, the Trustee shall select the Notes and such Senior Indebtedness shall be purchased on a pro rata basis based
on the accreted value or principal amount of the Notes or such Senior Indebtedness tendered. 
 (c) EFIH may, at its option,
make an Asset Sale Offer using proceeds from any Asset Sale at any time after consummation of such Asset Sale (other than an Asset Sale of Collateral or other Oncor-related Assets); provided that such Asset Sale Offer shall be in an aggregate
amount of not less than $25.0 million. Upon consummation of such Asset Sale Offer, any Net Proceeds not required to be used to purchase Notes shall not be deemed Excess Proceeds. 

(d) If EFIH or any of its Restricted Subsidiaries consummates an Asset Sale of Collateral or other Oncor-related Assets, within 10
Business Days of each date that the aggregate amount of Collateral Excess Proceeds exceeds $200.0 million, EFIH and/or any of its Restricted Subsidiaries shall make an offer to all Holders of the Notes and, if required or permitted by the terms of
any other Secured Lien Debt, to the holders of such other Secured Lien Debt (and if required or permitted by the terms of any Indebtedness of EFH Corp. that is guaranteed by EFIH and constitutes Secured Lien Debt, EFH Corp. may make an offer to all
holders of such Indebtedness) (a “Collateral Asset Sale Offer”), to purchase the maximum aggregate principal amount of such Secured Lien Debt that is a minimum of $2,000 or an integral multiple of $1,000 in excess thereof that may
be purchased out of the Collateral Excess Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, 

  
 A-6

 
plus accrued and unpaid interest (including Additional Interest, if any) to the date fixed for the closing of such offer, in accordance with the terms and procedures set forth in the Indenture
and the other applicable Secured Debt Documents; provided that in any such Collateral Asset Sale Offer, all Senior Lien Debt properly tendered will be purchased before any Junior Lien Debt is purchased; provided that in the event EFIH
or such Restricted Subsidiary cannot make an offer to the holders of Senior Lien Debt and holders of Junior Lien Debt at the same time, EFIH or such Restricted Subsidiary may make a Collateral Asset Sale Offer to the holders of Senior Lien Debt
first and make a Collateral Asset Sale Offer to the holders of Junior Lien Debt thereafter with any Collateral Excess Proceeds not used to purchase Senior Lien Debt as soon as practicable upon consummation of the Collateral Asset Sale Offer for the
Senior Lien Debt. To the extent that the aggregate amount of Notes and such Secured Lien Debt tendered pursuant to a Collateral Asset Sale Offer, or sequential Collateral Asset Sale Offers to holders of Senior Lien Debt and Junior Lien Debt as
provided for in the immediately preceding sentence, is less than the Collateral Excess Proceeds, EFIH and/or any of its Restricted Subsidiaries may use any remaining Collateral Excess Proceeds for general corporate purposes, subject to other
covenants contained in the Indenture. If the aggregate principal amount of Notes and other Secured Lien Debt surrendered by such holders thereof exceeds the amount of Collateral Excess Proceeds, all Senior Lien Debt properly tendered will be
purchased before any Junior Lien Debt is purchased and thereafter the Notes and any other Junior Lien Debt will be purchased on a pro rata basis based upon the accreted value or principal amount of the Notes or such other Junior Lien
Debt tendered. 
 (e) The Issuer (and, if applicable, EFH Corp.) may, at its option, make a Collateral Asset Sale Offer using
proceeds from any Asset Sale of Collateral or any other Oncor-related Assets at any time after consummation of such Asset Sale; provided that such Collateral Asset Sale Offer shall be in an aggregate amount of not less than $25.0 million.
Upon consummation of such Collateral Asset Sale Offer, or sequential Collateral Asset Sale Offers to holders of Senior Lien Debt and Junior Lien Debt, any Net Proceeds not required to be used to purchase Secured Lien Debt shall not be deemed
Collateral Excess Proceeds and the Issuer and EFIH’s Restricted Subsidiaries may use any remaining Net Proceeds for general corporate purposes, subject to the other covenants contained in the Indenture. 

(9) DENOMINATIONS, TRANSFER, EXCHANGE. The 2022 Second Lien Notes are
in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The transfer of 2022 Second Lien Notes may be registered and 2022 Second Lien Notes may be exchanged as provided in the Indenture. The
Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and the Issuer may require a Holder to pay any taxes and fees required by law or permitted by the Indenture. The Issuer
need not exchange or register the transfer of any 2022 Second Lien Notes or portion of 2022 Second Lien Notes selected for redemption, except for the unredeemed portion of any 2022 Second Lien Notes being redeemed in part. Also, the Issuer need not
exchange or register the transfer of any 2022 Second Lien Notes for a period of 15 days before a selection of 2022 Second Lien Notes to be redeemed. 
 (10) PERSONS DEEMED OWNERS. The registered Holder of a 2022 Second Lien Note may be treated as its owner for all purposes. 

  
 A-7

 (11) AMENDMENT, SUPPLEMENT AND
WAIVER. The Indenture, the Guarantees or the Notes may be amended or supplemented as provided in the Indenture. 
 (12) DEFAULTS AND REMEDIES. The Events of Default relating to the Notes are defined in Section 6.01 of the Indenture. If any Event
of Default occurs and is continuing, the Trustee or the Required Holders of at least 30% in aggregate principal amount of the then outstanding Required Debt may declare the principal of and premium, if any, interest (including Additional Interest,
if any) and any other monetary obligations on all the then outstanding Notes of the affected series to be due and payable immediately. Notwithstanding the foregoing, in the case of an Event of Default arising from certain events of bankruptcy or
insolvency, all principal of, and premium, if any, interest (including Additional Interest, if any) and any other monetary obligations on, all the then outstanding Notes will become due and payable immediately without further action or notice.
Holders may not enforce the Indenture, the Notes or the Guarantees except as provided in the Indenture. Subject to certain limitations, Required Holders of a majority in aggregate principal amount of the then outstanding Required Debt may direct the
Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of the Notes notice of any continuing Default (except a Default relating to the payment of principal, premium, if any, or interest (including Additional Interest,
if any)) if it determines that withholding notice is in their interest. The Required Holders of a majority in aggregate principal amount of the then outstanding Required Debt by notice to the Trustee may on behalf of the Required Holders of all of
the Required Debt waive any existing Default or and its consequences under the Indenture except a continuing Default in the payment of the principal of, or premium, if any, or interest (including Additional Interest, if any) on, any of the Notes
held by a non-consenting Holder. EFIH is required to deliver to the Trustee annually a statement regarding compliance with the Indenture, and EFIH is required within five Business Days after becoming aware of any Default, to deliver to the Trustee a
statement specifying such Default and what action EFIH proposes to take with respect thereto. 
 (13)
AUTHENTICATION. This 2022 Second Lien Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose until authenticated by the manual signature of the Trustee.

 (14) ADDITIONAL RIGHTS OF HOLDERS OF
RESTRICTED GLOBAL NOTES AND RESTRICTED DEFINITIVE NOTES. In addition to the rights provided to Holders of 2022 Second Lien
Notes under the Indenture, Holders of Restricted Global Notes and Restricted Definitive Notes shall have all the rights set forth in the Registration Rights Agreement, dated as of February 6, 2012, and the Registration Rights Agreement, dated
as of February 28, 2012, each among the Issuer and the other parties named on the signature pages thereof (together, the “Registration Rights Agreement”), relating to such 2022 Second Lien Notes, including the right to receive
Additional Interest, if any (as defined in the Registration Rights Agreement). 
 (15) GOVERNING LAW. THE INDENTURE, THE
2022 SECOND LIEN NOTES AND THE GUARANTEES SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

  
 A-8

 (16) CUSIP/ISIN NUMBERS. Pursuant to a
recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP/ISIN numbers to be printed on the 2022 Second Lien Notes and the Trustee may use CUSIP/ISIN numbers in notices of redemption as a
convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the 2022 Second Lien Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers
placed thereon. 
 The Issuer will furnish to any Holder upon written request and without charge a copy of the Indenture, the
Registration Rights Agreement relating to the 2022 Second Lien Notes and/or the Security Documents. Requests may be made to the Issuer at the following address: 
 Energy Future Intermediate Holding Company LLC 
 Energy Plaza 

1601 Bryan Street 

Dallas, Texas 75201-3411 
 Facsimile No.: (214) 812-6032 
 Attention: General Counsel 

And 
 Facsimile
No.: (214) 812-4097 
 Attention: Treasurer 
 And 
  
 EFIH
Finance Inc. 
 Energy Plaza 
 1601 Bryan Street 
 Dallas, Texas 75201-3411 

Facsimile No.: (214) 812-6032 
 Attention: General Counsel 
 And 

Facsimile No.: (214) 812-4097 
 Attention: Treasurer 

  
 A-9

 ASSIGNMENT FORM 

To assign this 2022 Second Lien Note, fill in the form below: 

 

			
	 (I) or (we) assign and transfer this 2022 Second Lien Note to:
	 	
		 	  

		 	(Insert assignee’s legal name)
	 (Insert assignee’s Soc.
Sec. or tax I.D. no.)
  

	 
	
	 
	
	 
	
	  
 (Print or type assignee’s name, address and zip code)

 and irrevocably appoint
                     to transfer this 2022 Second Lien Note on the books of the Issuer. The agent may substitute another to act for him.

  

					
	 Date:
                                
	  		  	
			
		  	Your Signature	  	  

		  		  	(Sign exactly as your name appears on the face of this 2022 Second Lien Note)
			
	 Signature Guarantee*:                   
             
	  		  	

  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

  
 A-10

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this 2022 Second Lien Note purchased by the Issuer pursuant to Section 4.10(d), 4.10(g) or 4.14 of the
Indenture, check the appropriate box below: 
  

					
	 ̈ Section 4.10(d)	 	 ̈ Section 4.10(g)	 	 ̈ Section 4.14

 If you want to elect to have only part of this 2022 Second Lien Note purchased by the Issuer pursuant to
Section 4.10(d), 4.10(g) or 4.14 of the Indenture, state the amount you elect to have purchased: 
  

									
		  	$	 		 		  	
		  		 	  
	 		  	
	Date:
                                        
	  		 		 		  	
		  		 	Your Signature:	 	 
		  		 		 	(Sign exactly as your name appears on the face of this 2022 Second Lien Note)
		  		 		 		  	
		  		 	Tax Identification No.:	  	 
	Signature Guarantee*:
                                         
                       	  		 		 		  	

  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

  
 A-11

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE2 
 The initial outstanding principal amount of this Global Note is $            . The following exchanges of a part of this Global Note for an
interest in another Global Note or for a Definitive Note, or exchanges of a part of another Global or Definitive Note for an interest in this Global Note, have been made: 

 

									
	 Date of Exchange
	  	Amount of
decrease in
Principal Amount	  	Amount of increase
in Principal
Amount of this
Global Note	  	Principal Amount
of this Global Note
following each
decrease or
increase	  	Signature of
authorized officer
of Trustee or
Custodian

  

 

	2 	 This schedule should be included only if the 2022 Second Lien Note is issued in global form. 

  
 A-12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}]]